Comparison of estimated treatment coverage for primaquine (blue) and tafenoquine (red) under the three main scenarios considered in this paper.

i) current prescribing restrictions (thick lines); ii) 8-aminoquinolines given to G6PD normal lactating women with infants older than 1 month (dashed lines); iii) alternative primaquine regimen for G6PD deficient individuals (dotted line).